CP-96-486

N/A

Report date: 2023/10/10 16:11:20

NME

Base Information

Drug NameCP-96-486

Drug Alias NameCP-96-486CP-96486CP-96,486

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPlatelet activating factor receptor antagonistsCysteinyl leukotriene receptor 1 antagonists

TargetsPlatelet activating factor receptorCysteinyl leukotriene receptor 1

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsAsthma

ATC CodeN/A